1. 1. Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol. 2011 Jan;7(1):31-40. doi: 10.1038/nrneurol.2010.178. [DOI:10.1038/nrneurol.2010.178] [PMID] []

2. Ghosh S, Sinha JK, Ghosh S, Sharma H, Bhaskar R, Narayanan KB. A Comprehensive Review of Emerging Trends and Innovative Therapies in Epilepsy Management. Brain Sci. 2023 Sep 11;13(9):1305. doi: 10.3390/brainsci13091305. [DOI:10.3390/brainsci13091305] [PMID] []

3. Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, Engel J Jr. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005 Apr;46(4):470-2. doi: 10.1111/j.0013-9580.2005.66104.x. [DOI:10.1111/j.0013-9580.2005.66104.x] [PMID]

4. GBD 2016 Epilepsy Collaborators. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 Apr;18(4):357-375. doi: 10.1016/S1474-4422(18)30454-X. [DOI:10.1016/S1474-4422(18)30454-X] [PMID]

5. Ngugi AK, Kariuki SM, Bottomley C, Kleinschmidt I, Sander JW, Newton CR. Incidence of epilepsy: a systematic review and meta-analysis. Neurology. 2011 Sep 6;77(10):1005-12. doi: 10.1212/WNL.0b013e31822cfc90. [DOI:10.1212/WNL.0b013e31822cfc90] [PMID] []

6. Wei CJ, Li W, Chen JF. Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies. Biochim Biophys Acta. 2011 May;1808(5):1358-79. doi: 10.1016/j.bbamem.2010.12.018. [DOI:10.1016/j.bbamem.2010.12.018] [PMID]

7. El Yacoubi M, Ledent C, Parmentier M, Costentin J, Vaugeois JM. Evidence for the involvement of the adenosine A(2A) receptor in the lowered susceptibility to pentylenetetrazol-induced seizures produced in mice by long-term treatment with caffeine. Neuropharmacology. 2008 Jul;55(1):35-40. doi: 10.1016/j.neuropharm.2008.04.007. [DOI:10.1016/j.neuropharm.2008.04.007] [PMID]

8. van Calker D, Biber K, Domschke K, Serchov T. The role of adenosine receptors in mood and anxiety disorders. J Neurochem. 2019 Oct;151(1):11-27. doi: 10.1111/jnc.14841. [DOI:10.1111/jnc.14841] [PMID]

9. Baltos JA, Casillas-Espinosa PM, Rollo B, Gregory KJ, White PJ, Christopoulos A, Kwan P, O'Brien TJ, May LT. The role of the adenosine system in epilepsy and its comorbidities. Br J Pharmacol. 2023 Apr 19. doi: 10.1111/bph.16094. [DOI:10.1111/bph.16094] [PMID]

10. Asadi-Pooya AA, Zeraatpisheh Z, Rostaminejad M, Damabi NM. Caffeinated drinks, fruit juices, and epilepsy: A systematic review. Acta Neurol Scand. 2022 Feb;145(2):127-138. doi: 10.1111/ane.13544. [DOI:10.1111/ane.13544] [PMID]

11. Souza MA, Mota BC, Gerbatin RR, Rodrigues FS, Castro M, Fighera MR, Royes LF. Antioxidant activity elicited by low dose of caffeine attenuates pentylenetetrazol-induced seizures and oxidative damage in rats. Neurochem Int. 2013 May;62(6):821-30. doi: 10.1016/j.neuint.2013.02.021. [DOI:10.1016/j.neuint.2013.02.021] [PMID]

12. Butt MS, Sultan MT. Coffee and its consumption: benefits and risks. Crit Rev Food Sci Nutr. 2011 Apr;51(4):363-73. doi: 10.1080/10408390903586412. [DOI:10.1080/10408390903586412] [PMID]

13. Esmaili Z, Heydari A. Effect of acute caffeine administration on PTZ-induced seizure threshold in mice: Involvement of adenosine receptors and NO-cGMP signaling pathway. Epilepsy Res. 2019 Jan;149:1-8. doi: 10.1016/j.eplepsyres.2018.10.013. [DOI:10.1016/j.eplepsyres.2018.10.013] [PMID]

14. Germé K, Faure JB, Koning E, Nehlig A. Effect of caffeine and adenosine receptor ligands on the expression of spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg (GAERS). Epilepsy Res. 2015 Feb;110:105-14. doi: 10.1016/j.eplepsyres.2014.11.022. [DOI:10.1016/j.eplepsyres.2014.11.022] [PMID]

15. Zhang Y, Liu Y, Sun J, Zhang W, Guo Z, Ma Q. Arachidonic acid metabolism in health and disease. MedComm (2020). 2023 Sep 20;4(5):e363. doi: 10.1002/mco2.363. [DOI:10.1002/mco2.363] [PMID] []

16. Daghigh F, Noureddini M, Takhtefirouzeh M, Heydari A. The effect of indomethacin on pentylenetetrazole-induced kindling in male rats. Feyz 2014; 18 (4) :286-291

17. Rojas A, Jiang J, Ganesh T, Yang MS, Lelutiu N, Gueorguieva P, Dingledine R. Cyclooxygenase-2 in epilepsy. Epilepsia. 2014 Jan;55(1):17-25. doi: 10.1111/epi.12461. [DOI:10.1111/epi.12461] [PMID] []

18. Sluter MN, Li Q, Yasmen N, Chen Y, Li L, Hou R, Yu Y, Yang CY, Meibohm B, Jiang J. The inducible prostaglandin E synthase (mPGES-1) in neuroinflammatory disorders. Exp Biol Med (Maywood). 2023 May;248(9):811-819. doi: 10.1177/15353702231179926. [DOI:10.1177/15353702231179926] [PMID] []

19. Zandieh A, Maleki F, Hajimirzabeigi A, Zandieh B, Khalilzadeh O, Dehpour AR. Anticonvulsant effect of celecoxib on pentylenetetrazole-induced convulsion: Modulation by NO pathway. Acta Neurobiol Exp (Wars). 2010;70(4):390-7. doi: 10.55782/ane-2010-1811. [DOI:10.55782/ane-2010-1811] [PMID]

20. Katyal J, Kumar H, Gupta YK. Anticonvulsant activity of the cyclooxygenase-2 (COX-2) inhibitor etoricoxib in pentylenetetrazole-kindled rats is associated with memory impairment. Epilepsy Behav. 2015 Mar;44:98-103. doi: 10.1016/j.yebeh.2014.12.032. [DOI:10.1016/j.yebeh.2014.12.032] [PMID]

21. Cadieux JS, Leclerc P, St-Onge M, Dussault AA, Laflamme C, Picard S, Ledent C, Borgeat P, Pouliot M. Potentiation of neutrophil cyclooxygenase-2 by adenosine: an early anti-inflammatory signal. J Cell Sci. 2005 Apr 1;118(Pt 7):1437-47. doi: 10.1242/jcs.01737. [DOI:10.1242/jcs.01737] [PMID] []

22. Pouliot M, Fiset ME, Massé M, Naccache PH, Borgeat P. Adenosine up-regulates cyclooxygenase-2 in human granulocytes: impact on the balance of eicosanoid generation. J Immunol. 2002 Nov 1;169(9):5279-86. doi: 10.4049/jimmunol.169.9.5279. [DOI:10.4049/jimmunol.169.9.5279] [PMID]

23. Jenabian N, Moghadamnia AA, Beyraghshamshir R. Clinical Efficacy of Celecoxib with and without Caffeine versus Ibuprofen for Pain Control following Crown Lengthening Surgery. J Dent Sch [Internet]. 2019 Mar. 11 [cited 2024 Feb. 7];33(1):51-8.

24. Akula KK, Dhir A, Kulkarni SK. Nitric oxide signaling pathway in the anti-convulsant effect of adenosine against pentylenetetrazol-induced seizure threshold in mice. Eur J Pharmacol. 2008 Jun 10;587(1-3):129-34. doi: 10.1016/j.ejphar.2008.03.038. [DOI:10.1016/j.ejphar.2008.03.038] [PMID]

25. Mesdaghinia A, Khazaee P, Heydari A. The effect of cyclooxygenase-2 inhibition on pentylenetetrazole-induced seizure threshold in mice. Feyz 2018; 22 (3) :258-266

26. Bankstahl M, Bankstahl JP, Bloms-Funke P, Löscher W. Striking differences in proconvulsant-induced alterations of seizure threshold in two rat models. Neurotoxicology. 2012 Jan;33(1):127-37. doi: 10.1016/j.neuro.2011.12.011. [DOI:10.1016/j.neuro.2011.12.011] [PMID]

27. Jargiełło-Baszak M, Chrościńska-Krawczyk M, Andres-Mach M, Łuszczki JJ, Czuczwar SJ. Influence of caffeine on the protective activity of gabapentin and topiramate in a mouse model of generalized tonic-clonic seizures. Pharmacol Rep. 2016 Aug;68(4):680-5. doi: 10.1016/j.pharep.2016.03.011. [DOI:10.1016/j.pharep.2016.03.011] [PMID]

28. Taketo M. Activation of adenosine A1 receptor potentiates metabotropic glutamate receptor 1-mediated Ca2+ mobilization in the rat hippocampal marginal zone. Brain Res. 2023 Dec 15;1821:148581. doi: 10.1016/j.brainres.2023.148581. [DOI:10.1016/j.brainres.2023.148581] [PMID]

29. Wang YJ, Hsieh CP, Chan MH, Chan TY, Chen L, Chen HH. Distinct effects of resveratrol on seizures and hyperexcitability induced by NMDA and 4-aminopyridine. Nutr Neurosci. 2019 Dec;22(12):867-876. doi: 10.1080/1028415X.2018.1461458. [DOI:10.1080/1028415X.2018.1461458] [PMID]

30. Ribeiro JA, Sebastião AM, de Mendonça A. Adenosine receptors in the nervous system: pathophysiological implications. Prog Neurobiol. 2002 Dec;68(6):377-92. doi: 10.1016/s0301-0082(02)00155-7. [DOI:10.1016/S0301-0082(02)00155-7] [PMID]

31. Haskó G, Cronstein BN. Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 2004 Jan;25(1):33-9. doi: 10.1016/j.it.2003.11.003. [DOI:10.1016/j.it.2003.11.003] [PMID]

32. Tescarollo FC, Rombo DM, DeLiberto LK, Fedele DE, Alharfoush E, Tomé ÂR, Cunha RA, Sebastião AM, Boison D. Role of Adenosine in Epilepsy and Seizures. J Caffeine Adenosine Res. 2020 Jun 1;10(2):45-60. doi: 10.1089/caff.2019.0022. [DOI:10.1089/caff.2019.0022] [PMID] []

33. Stockwell J, Jakova E, Cayabyab FS. Adenosine A1 and A2A Receptors in the Brain: Current Research and Their Role in Neurodegeneration. Molecules. 2017 Apr 23;22(4):676. doi: 10.3390/molecules22040676 [DOI:10.3390/molecules22040676] [PMID] []

34. Temp FR, Marafiga JR, Milanesi LH, Duarte T, Rambo LM, Pillat MM, Mello CF. Cyclooxygenase-2 inhibitors differentially attenuate pentylenetetrazol-induced seizures and increase of pro- and anti-inflammatory cytokine levels in the cerebral cortex and hippocampus of mice. Eur J Pharmacol. 2017 Sep 5;810:15-25. doi: 10.1016/j.ejphar.2017.05.013. [DOI:10.1016/j.ejphar.2017.05.013] [PMID]

35. López DE, Ballaz SJ. The Role of Brain Cyclooxygenase-2 (Cox-2) Beyond Neuroinflammation: Neuronal Homeostasis in Memory and Anxiety. Mol Neurobiol. 2020 Dec;57(12):5167-5176. doi: 10.1007/s12035-020-02087-x. [DOI:10.1007/s12035-020-02087-x] [PMID]

36. Takemiya T, Suzuki K, Sugiura H, Yasuda S, Yamagata K, Kawakami Y, Maru E. Inducible brain COX-2 facilitates the recurrence of hippocampal seizures in mouse rapid kindling. Prostaglandins Other Lipid Mediat. 2003 Jul;71(3-4):205-16. doi: 10.1016/s1098-8823(03)00040-6. [DOI:10.1016/S1098-8823(03)00040-6] [PMID]

37. Fiebich BL, Lieb K, Hüll M, Aicher B, van Ryn J, Pairet M, Engelhardt G. Effects of caffeine and paracetamol alone or in combination with acetylsalicylic acid on prostaglandin E(2) synthesis in rat microglial cells. Neuropharmacology. 2000 Aug 23;39(11):2205-13. doi: 10.1016/s0028-3908(00)00045-9. [DOI:10.1016/S0028-3908(00)00045-9] [PMID]

38. Chen S, Wu Q, Zhong D, Li C, Du L. Caffeine prevents hyperoxia-induced lung injury in neonatal mice through NLRP3 inflammasome and NF-κB pathway. Respir Res. 2020 Jun 8;21(1):140. doi: 10.1186/s12931-020-01403-2. [DOI:10.1186/s12931-020-01403-2] [PMID] []